1. Home
  2. Analysis
  3. Slow-k
  4. Thinking-abnormal

Slow-k and Thinking abnormal - a phase IV clinical study of FDA data

Summary:

Thinking abnormal is reported as a side effect among people who take Slow-k (potassium chloride), especially for people who are female, 50-59 old, also take Spironolactone, and have Bladder spasm.

The phase IV clinical study analyzes which people have Thinking abnormal when taking Slow-k. It is created by eHealthMe based on reports of 3,640 people who have side effects when taking Slow-k from the FDA, and is updated regularly.

What is Slow-k?

Slow-k has active ingredients of potassium chloride. It is often used in hypokalemia. eHealthMe is studying from 3,683 Slow-k users. Check the latest studies of Slow-k.

What is Thinking abnormal?

Thinking abnormal is found to be associated with 1,061 drugs and 1,184 conditions by eHealthMe. Check the latest studies of Thinking abnormal.

On Jul, 23, 2026

3,640 people reported to have side effects when taking Slow-k.
Among them, 14 people (0.38%) have Thinking abnormal.

Could Slow-k cause Thinking abnormal?

Among these 14 people:

What is the gender of people who have Thinking abnormal when taking Slow-k? *

  • female: 100 %
  • male: 0.0 %

What is the age of people who have Thinking abnormal when taking Slow-k? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 100 %
  • 60+: 0.0 %

What are other drugs people take besides Slow-k? *

  1. Levothyroxine Sodium: 14 people, 100.00%
  2. Clopidogrel Bisulfate: 14 people, 100.00%
  3. Risedronate Sodium: 14 people, 100.00%
  4. Prednisone: 14 people, 100.00%
  5. Pantoprazole Sodium: 14 people, 100.00%
  6. Ondansetron: 14 people, 100.00%
  7. Myrbetriq: 14 people, 100.00%
  8. Methylprednisolone Sodium Succinate: 14 people, 100.00%
  9. Benadryl: 14 people, 100.00%
  10. Spironolactone: 14 people, 100.00%

What are other side effects people have besides Thinking abnormal? *

  1. Weight Increased: 14 people, 100.00%
  2. Cerebral Disorder (brain disease): 14 people, 100.00%
  3. Facial Paralysis (loss of function of face muscle): 14 people, 100.00%
  4. Fall: 14 people, 100.00%
  5. Fatigue (feeling of tiredness): 14 people, 100.00%
  6. Bladder Spasm: 14 people, 100.00%
  7. Hypoaesthesia (reduced sense of touch or sensation): 14 people, 100.00%
  8. Vision Blurred: 14 people, 100.00%
  9. Limb Injury: 14 people, 100.00%
  10. Loss Of Bladder Sensation (can not feel the urge of urination): 14 people, 100.00%

What are the existing conditions these people have? *

  1. Encephalitis Autoimmune (autoimmune origin disturbances of consciousness and pyramidal signs, inflammation of the brain): 14 people, 100.00%
  2. Bladder Spasm: 14 people, 100.00%
  3. Urinary Tract Infection: 6 people, 42.86%

* Approximation only. Some reports may have incomplete information.

Do you take Slow-k and have Thinking abnormal?

- Check whether Thinking abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Slow-k:

Thinking abnormal treatments and more:

How severe was Thinking abnormal and when was it recovered:

Expand to all the drugs that have ingredients of potassium chloride:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Slow-k:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Thinking abnormal:

Browse all the conditions that are associated with Thinking abnormal:

How the study uses the data?

The study uses data from the FDA. It is based on potassium chloride (the active ingredients of Slow-k) and Slow-k (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.